Gain Therapeutics
Price & Volume
Stats
See more52W Range | $0.89-$3.65 |
Market Cap | $50M |
Shares Short | 302,677 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$10.6M |
Diluted EPS | -$0.89 |
News
See moreYahoo Finance • 8 days ago
Is Gain Therapeutics (GANX) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?
Yahoo Finance • 22 days ago
Gain Therapeutics Announces Poster Presentation at AD/PD 2025
Yahoo Finance • 23 days ago
Gain Therapeutics Reports Financial Results for the Fourth Quarter and Year End 2024 and Provides Corporate Update
Yahoo Finance • last month
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease
About
CEO | Mr. Gene Mack M.B.A. |
Address | 4800 Montgomery Lane, Bethesda, MD, United States, 20814 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 23 |
